Blog

ESMO recommendations released to provide a roadmap to facilitate the implementation of MTBs in clinical practice

ESMO/LinkedIn

Apr 8, 2025, 18:01

ESMO recommendations released to provide a roadmap to facilitate the implementation of MTBs in clinical practice

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

“New ESMO recommendations released to provide a roadmap to facilitate the implementation of molecular tumour boards (MTBs) in clinical practice.

The recommendations published in Annals of Oncology provide a structured framework to:

Define core MTB composition
Establish structured workflows for case selection, data integration & follow-up
Set documentation and reporting standards
Introduce quality indicators to assess MTB performance

These are some of the key areas to be addressed to foster consistent and effective MTB operations across diverse healthcare environments and to optimise precision oncology.

Read the ESMO Daily Reporter article.”

More posts featuring ESMO.

Annals of Oncology cancer ESMO ESMO Daily Reporter ESMO Recommendations European Society for Medical Oncology molecular tumour boards MTBs OncoDaily Oncology

HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up

TOPGEAR trial at ESTRO 2025: Preoperative Chemoradiotherapy for Resectable Gastric Cancer

NIVOPOSTOP (GORTEC 2018-01): A Phase III Trial of Adjuvant Nivolumab in High-Risk Resected Head and Neck Squamous Cell Carcinoma

Bianca Balti: The Supermodel’s Brave Battle with Ovarian Cancer

NCD Frontlines with Saunthari Somasundaram | A New OncoDaily Podcast – Coming Soon